Sandra Santos

Director
BioMarin Pharmaceuticals Inc.
Novato, California, United States

Presentation(s):

• PB0229 - Results from the Taiwanese cohort in GENEr8-1: bleeding rates, factor VIII usage, quality of life and safety in severe Hemophilia A patients after gene therapy

  Sunday, June 23, 2024
  13:45 – 14:45 ICT